Get started
RocketTickers

Biohaven's NURTEC(TM) ODT (rimegepant) Receives FDA Approval for

Long
Biohaven Ltd. (NYSE:BHVN)  
RocketTickers  
NYSE:BHVN   Biohaven Ltd.
Beyond Technical Analysis
2
0
beyondta
BHVN: Biohaven Pharmaceutical Holding Company Ltd.
2020-02-27 16:11:00
Biohaven's NURTEC(TM) ODT (rimegepant) Receives FDA Approval for the Acute Treatment of Migraine in Adults
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.